NAME :- SUMATRIPTAN SUCCINATE
IUPAC NAME :- 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide
CAS NO. :- 103628-48-4
FORMULA :- C18H27N3O6S
SYNONYMS :- gr43175c;SuMitrex;Sumatriptan succinate;methanesulfonamide(1:1);SuMatriptan Succinate, EP;SUMATRIPTANSUCCINATE(1:1);Sumatriptan Succinate (200 mg);3-[2-(DIMETHYLAMINO) ETHYL]-N-METHYL-1H-INDOLE-5-METHANE SULFONAMIDE;compd.with3-(2-(dimethylamino)ethyl)-n-methyl-1h-indole-5-butanedioicaci;3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl-N-methylmethanesulfonamide Succinate
APPLICATION :- A selective 5-HT1 receptor agonist
DESCRIPTION :- Sumatriptan succinate is a selective 5-HT1 receptor agonist with specificity towards 5-HT1D, 5-HT1B and 5-HT1A. In addition, the physicochemical properties of Sumatriptan succinate can be characterized using FT-IR, HPLC, SEM and XRD. It has been reported that Sumatriptan succinate can be produced via reactive precipitation without the presence of surfactants. Further studies show that molecules of Sumatriptan succinate are carried through cells using liposomes, with positively charged liposomes exhibiting the highest loading efficiency.
Developed and Managed by Infocom Network Private Limited.